Literature DB >> 8495199

Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.

T L Bigler1, W Lu, S J Park, M Tashiro, M Wieczorek, R Wynn, M Laskowski.   

Abstract

In the association of serine proteinases with their cognate substrates and inhibitors an important interaction is the fitting of the P1 side chain of the substrate or inhibitor into a preformed cavity of the enzyme called the S1 pocket. In turkey ovomucoid third domain, which is a canonical protein proteinase inhibitor, the P1 residue is Leu18. Here we report the values of equilibrium constants, Ka, for turkey ovomucoid third domain and 13 additional Leu18X variants with six serine proteinases: bovine alpha chymotrypsin A, porcine pancreatic elastase, subtilisin Carlsberg, Streptomyces griseus proteinases A and B, and human leukocyte elastase. Eight of the Xs are coded amino acids: Ala, Ser, Val, Met, Gln, Glu, Lys, and Phe, and five are noncoded: Abu, Ape, Ahx, Ahp, and Hse. They were chosen to simplify the interamino acid comparisons. In the homologous series of straight-chain side chains Ala, Abu, Ape, Ahx, Ahp, free energy of binding decreases monotonically with the side-chain length for chymotrypsin with large binding pocket, but even for this enzyme shows curvature. For the two S. griseus enzymes a minimum appears to be reached at Ahp. A minimum is clearly evident for the two elastases, where increasing the side-chain length from Ahx to Ahp greatly weakens binding, but much more so for the apparently more rigid pancreatic enzyme than for the more flexible leukocyte enzyme. beta-Branching (Ape/Val) is very deleterious for five of the six enzymes; it is only slightly deleterious for the more flexible human leukocyte elastase. The effect of gamma-branching (Ahx/Leu), of introduction of heteroatoms (Abu/Ser), (Ape/Hse), and (Ahx/Met), and of introduction of charge (Gln/Glu) and (Ahp/Lys) are tabulated and discussed. An important component of the free energy of interaction is the distortion of the binding pocket by bulky or branched side chains. Most of the variants studied were obtained by enzymatic semisynthesis. X18 variants of the 6-18 peptide GlyNH2 were synthesized and combined with natural reduced peptide 19-56. Disulfide bridges were formed. The GlyNH2 was removed and the reactive-site peptide bond X18-Glu19 was synthesized by complex formation with proteinase K. The resultant complexes were dissociated by sudden pH drop. This kinetically controlled dissociation afforded virgin, reactive-site-intact inhibitor variants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495199      PMCID: PMC2142496          DOI: 10.1002/pro.5560020509

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

1.  COSMIC analysis of the major alpha-helix of barnase during folding.

Authors:  A Horovitz; L Serrano; A R Fersht
Journal:  J Mol Biol       Date:  1991-05-05       Impact factor: 5.469

2.  Probing protein stability with unnatural amino acids.

Authors:  D Mendel; J A Ellman; Z Chang; D L Veenstra; P A Kollman; P G Schultz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

3.  Effect of single amino acid replacements on the thermodynamics of the reactive site peptide bond hydrolysis in ovomucoid third domain.

Authors:  W Ardelt; M Laskowski
Journal:  J Mol Biol       Date:  1991-08-20       Impact factor: 5.469

4.  Semisynthetic engineering of proteinase inhibitor homologues.

Authors:  H Tschesche; J Beckmann; A Mehlich; E Schnabel; E Truscheit; H R Wenzel
Journal:  Biochim Biophys Acta       Date:  1987-05-27

5.  Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey.

Authors:  M Fujinaga; R J Read; A Sielecki; W Ardelt; M Laskowski; M N James
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor.

Authors:  E Weber; E Papamokos; W Bode; R Huber; I Kato; M Laskowski
Journal:  J Mol Biol       Date:  1981-06-15       Impact factor: 5.469

7.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

8.  Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution.

Authors:  M Fujinaga; A R Sielecki; R J Read; W Ardelt; M Laskowski; M N James
Journal:  J Mol Biol       Date:  1987-05-20       Impact factor: 5.469

9.  Probing steric and hydrophobic effects on enzyme-substrate interactions by protein engineering.

Authors:  D A Estell; T P Graycar; J V Miller; D B Powers; J A Wells; J P Burnier; P G Ng
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

10.  X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor.

Authors:  W Bode; A Z Wei; R Huber; E Meyer; J Travis; S Neumann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  10 in total

1.  Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.

Authors:  Zhibin Wu; Jerry Alexandratos; Bryan Ericksen; Jacek Lubkowski; Robert C Gallo; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

2.  Prediction of protein complexes using empirical free energy functions.

Authors:  Z Weng; S Vajda; C Delisi
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

3.  Interaction of subtilisins with serpins.

Authors:  T Komiyama; H Grøn; P A Pemberton; G S Salvesen
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

4.  The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.

Authors:  Moh'd A Salameh; Alexei S Soares; Alexandra Hockla; Derek C Radisky; Evette S Radisky
Journal:  Biochem J       Date:  2011-11-15       Impact factor: 3.857

5.  Deleterious effects of beta-branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB.

Authors:  K S Bateman; S Anderson; W Lu; M A Qasim; M Laskowski; M N James
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

Review 6.  GPCR regulation of secretion.

Authors:  Yun Young Yim; Zack Zurawski; Heidi Hamm
Journal:  Pharmacol Ther       Date:  2018-07-26       Impact factor: 12.310

7.  Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.

Authors:  Zhibin Wu; David M Hoover; De Yang; Cyril Boulègue; Fanny Santamaria; Joost J Oppenheim; Jacek Lubkowski; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

8.  Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.

Authors:  Mary E Klotman; Aprille Rapista; Natalia Teleshova; Amanda Micsenyi; Gary A Jarvis; Wuyuan Lu; Edith Porter; Theresa L Chang
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB).

Authors:  Mohammad A Qasim; Lixia Wang; Sabiha Qasim; Stephen Lu; Wuyuan Lu; Richard Wynn; Zheng-Ping Yi; Michael Laskowski
Journal:  FEBS Lett       Date:  2013-07-23       Impact factor: 4.124

10.  Quantitative Multiple-Reaction Monitoring Proteomic Analysis of Gβ and Gγ Subunits in C57Bl6/J Brain Synaptosomes.

Authors:  Yun Young Yim; W Hayes McDonald; Karren Hyde; Osvaldo Cruz-Rodríguez; John J G Tesmer; Heidi E Hamm
Journal:  Biochemistry       Date:  2017-09-21       Impact factor: 3.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.